Abstract
Introduction

50
In 2004, artemisinin combination therapy (ACT) was adopted in Suriname as part of its malaria control falciparum infection presenting at the clinic.
106
DNA isolation and genotyping methods
107
Genomic DNA was isolated from blood spots taken at enrollment (Day 0) using the QIAamp DNA mini 108 kit (QIAGEN, Valencia, CA). Samples were screened using the multiplex PET-PCR (7). For each 109 sample, duplicate PET-PCR reactions were run with 5 μL of DNA template used in the PCR reaction.
110
All assays were performed using Agilent Mx3005pro thermocyclers (Agilent technologies, Santa Clara, 111 CA, USA). As previously established, a CT value of 40 was considered the cut-off value to score a 112 reaction as positive, samples above 40 were considered to be negative. The confirmed P. falciparum 113 samples were used to amplify the K13-propeller domain using previously described methods (6 was run independently ten times with a burn-in period of 10,000 iterations followed by 50,000 iterations.
151
The admixture model was used allowing for the presence of individuals with ancestry in two or more of 152 the K populations. Heterozygosity (He) and the fixation index (FST) were calculated using Arlequin 
Results
157
A total of 40 out of 41 samples were positive for P. falciparum according to our PET-PCR results; 38 of 158 these samples successfully amplified for all genes. From these samples, 7 displayed a mixed P. American 7G8 laboratory strain (Table 1) .
Also, the Pfcrt mutation I356L was found in all isolates from Suriname, as well as an insertion of four
167
AT repetitive motifs in positions 2477 to 2485. These samples also exhibited the Pfcrt double mutant 168 C72S/K76T, the Pfdhps triple mutant A437G/K540E/A581G and the Pfdhfr triple mutant 169 C50R/N51I/S108N (Table 2 ). More importantly, the Pfcrt C350R mutation, recently described as a 170 reverse phenotypic mutation associated with CQ sensitivity and associated with piperaquine resistance,
171
was found in 62% of the samples. We also found two Pfmdr1 mutant genotypes,
172
Y184F/N1042D/D1246Y (triple mutant) and Y184F/S1034C/N1042D/D1246Y (quadruple mutant). The
173
Pfmdr1 copy number determination indicated that only a single sample had 2 gene copies. The
174
frequency of mutations and the copy number results are shown in Figure 2 .
175
Neutral microsatellite analysis
176
We found at least 12 different neutral microsatellite haplotypes from Suriname and its bordering regions 177 in these Surinamese samples (Table 3) . By doing a comparative analysis of our data with previously 178 reported data from Suriname (12) and Guyana (6), we found at least two Plasmodium populations
179
represented by the red and green clusters (Figure 3a) . Each cluster is composed of highly similar P.
180
falciparum haplotypes. Moreover, using tests of genetic differentiation between sampling populations 181 (FST), we found that there was little genetic differentiation between Venezuela-Guyana, Venezuela-
182
Suriname, Venezuela-Brazil, Guyana-Brazil and Brazil-Suriname (Figure 3b ; and green) were shared by both countries. Suriname are highly genetically related and behaved as a single parasite population.
247
Although K13 genotypes associated with artemisinin resistance were not detected, our findings highlight Table 1 . Aminoacid mutations found in genomic markers associated with K13 resistance mutations.
271
Genetic background mutations associated with artemisinin resistance previously found in Southeast Asia 272 are in bold and underscored. Locus Genotype
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Genes related to artemisinin resistance and mutations found within these genes. 
